Related Experiment Video
Updated: Jun 18, 2025

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
Autophagic degradation of CDK4 is responsible for G0/G1 cell cycle arrest in NVP-BEZ235-treated neuroblastoma
Zhen Liu1,2, Xiao-Yang Wang3, Han-Wei Wang4
1Department of Clinical Laboratory, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, China.
Background:
CDK4 is highly expressed and associated with poor prognosis and decreased survival in advanced neuroblastoma (NB). Targeting CDK4 degradation presents a potentially promising therapeutic strategy compared to conventional CDK4 inhibitors. However, the autophagic degradation of the CDK4 protein and its anti-proliferation effect in NB cells has not been mentioned.
Results:
We identified autophagy as a new pathway for the degradation of CDK4. Firstly, autophagic degradation of CDK4 is critical for NVP-BEZ235-induced G0/G1 arrest, as demonstrated by the overexpression of CDK4, autophagy inhibition, and blockade of autophagy-related genes. Secondly, we present the first evidence that p62 binds to CDK4 and then enters the autophagy-lysosome to degrade CDK4 in a CTSB-dependent manner in NVP-BEZ235 treated NB cells. Similar results regarding the interaction between p62 and CDK4 were observed in the NVP-BEZ235 treated NB xenograft mouse model.
Conclusions:
Autophagic degradation of CDK4 plays a pivotal role in G0/G1 cell cycle arrest in NB cells treated with NVP-BEZ235.
Insights
Targeting CDK4 degradation via autophagy is a novel therapeutic strategy for neuroblastoma (NB). This study reveals that autophagy, mediated by p62 and CTSB, degrades CDK4, inducing cell cycle arrest in NB cells.
Area of Science:
- Oncology
- Cell Biology
- Molecular Medicine
Background:
- Cyclin-dependent kinase 4 (CDK4) is highly expressed in advanced neuroblastoma (NB), correlating with poor prognosis and reduced survival.
- Targeting CDK4 degradation offers a promising therapeutic avenue beyond traditional CDK4 inhibitors.
- The role of autophagic degradation of CDK4 and its anti-proliferative effects in NB cells remained uncharacterized.
Purpose of the Study:
- To investigate the role of autophagy in CDK4 degradation within neuroblastoma cells.
- To elucidate the mechanism of CDK4 autophagic degradation and its impact on cell cycle progression.
- To explore the therapeutic potential of targeting CDK4 degradation in neuroblastoma.
Main Methods:
- Investigated CDK4 degradation using autophagy inhibition and gene blockade in NVP-BEZ235 treated NB cells.
- Utilized p62 and CTSB (cathepsin B) to demonstrate the mechanism of CDK4 binding and lysosomal degradation.
- Validated findings in a neuroblastoma xenograft mouse model.
Main Results:
- Autophagic degradation of CDK4 was identified as a critical mechanism for NVP-BEZ235-induced G0/G1 cell cycle arrest.
- Overexpression of CDK4 and inhibition of autophagy confirmed the dependency of cell cycle arrest on CDK4 degradation.
- p62 was found to bind CDK4, facilitating its lysosomal degradation in a CTSB-dependent manner in NB cells and xenografts.
Conclusions:
- Autophagic degradation of CDK4 is a key mediator of G0/G1 cell cycle arrest in neuroblastoma cells treated with NVP-BEZ235.
- This pathway represents a novel therapeutic target for neuroblastoma treatment.
Related Concept Videos
Inhibition of Cdk Activity
Negative Regulator Molecules
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...
DNA Damage can Stall the Cell Cycle
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...

